Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Inflammation & Allergy Drug Targets|March 17, 2010
Predictive factors for disability as evaluated by the health assessment questionnaire in rheumatoid arthritis: a literature reviewEric Toussirot
Expert Opinion on Pharmacotherapy|January 19, 2017
New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agentsEric Toussirot
Expert Opinion on Biological Therapy|December 1, 2017
Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritisEric Toussirot
Frontiers in Medicine|December 3, 2021
The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current InsightsEric Toussirot
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current InsightsEric Toussirot
Frontiers in Endocrinology|January 11, 2021
Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic DiseasesEric Toussirot
Biomedicines|February 25, 2023
The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic DiseasesEric Toussirot
Expert Opinion on Pharmacotherapy|May 17, 2019
Pharmacological management of axial spondyloarthritis in adultsEric Toussirot
Arthritis Research & Therapy|March 18, 2006
HLA-DRB1 genes and extraarticular rheumatoid arthritisJean Roudier
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
Pageof 16